Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
- 1 October 2005
- report
- Published by National Bureau of Economic Research
Abstract
No abstract availableThis publication has 0 references indexed in Scilit:
This publication has 0 references indexed in Scilit: